Post-ICU Palliative Care Intervention (PIPCI) Trial
Post-ICU Palliative Care Consultation Intervention Pilot Trial in Older Survivors of Acute Respiratory Failure
This is a single center, pilot, randomized, single-blind, usual care controlled, pragmatic clinical trial of a post-ICU palliative care consultation intervention in older (age ≥50 years) survivors of acute respiratory failure.
Aim 1: To conduct a pilot post-ICU palliative care consultation intervention trial among frail older ICU survivors and their surrogates. Hypothesis:The Investigators can achieve an adequate enrollment rate, protocol adherence, and intervention fidelity.
Aim 2: To estimate effect sizes and variability for changes in symptoms at hospital discharge and 1 month, and to estimate hospice referral rates and acute-care readmission rates at 1 and 3 months. Hypothesis: Effect sizes and feasibility data will inform and support future post-ICU palliative care studies focused on improving ICU survivorship.
Exploratory Aim. To assess the use of methylphenidate that is recommended and dosed by the palliative care physician for the treatment of moderate-to-severe fatigue. Hypothesis: (1) Not all patients with moderate-to-severe fatigue will be recommended for methylphenidate therapy. (2) Patients prescribed methylphenidate for treatment of moderate-to-severe fatigue after critical illness will adhere to methylphenidate therapy.
연구 개요
상세 설명
There is an urgent need for research to improve outcomes for the rapidly growing population of older survivors of critical illness. Most adults, including older adults, survive critical illness. While recovery with minimal sequelae occurs, a substantial proportion of survivors are left with physical disability and cognitive impairment, have an increased risk of death, and incur high health care costs after hospital discharge. In prior work the Investigators have shown that about 75% of older survivors of respiratory failure are phenotypically frail and that these frail ICU survivors have a high burden of uncontrolled symptoms at hospital discharge and 1-month later. Moderate to severe post-ICU fatigue is the most prevalent symptom and may interfere with functional recovery.
This study is designed to determine whether consultation with a palliative care team may help alleviate any physical symptoms or psychological distress that the patients and their caregivers (surrogates) have coming out of the ICU.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
New York
-
New York, New York, 미국, 10032
- Columbia University Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age ≥ 50 years.
- Acute respiratory failure requiring invasive mechanical ventilation, non-invasive mechanical ventilation (continuous or bi-level positive pressure), or high flow nasal cannula for greater than 24 hours in a Columbia University Medical Center medical or surgical ICU.
Exclusion Criteria:
- Hospital discharge directly from ICU.
- Already received palliative care consultation during the hospitalization.
- Planned discharge to hospice or home hospice. These patients do not need further palliative care consultation since they have already decided on prioritizing palliative care over life-sustaining treatment.
- Respiratory failure due to neurologic diagnosis (intracranial hemorrhage, stroke, or coma). These patients are unlikely to be able to participate in any frailty measurements, and may have difficulty with communicating their symptom burden.
- Pre-existing neurologic disease or stroke with motor deficits. Older adults with motor diseases (e.g Parkinson's disease) will be excluded from frailty measurements because they could present with frailty characteristics from a single disease. This criterion was used to exclude subjects in the original Cardiovascular Health Study from which the Fried frailty phenotype was first assessed.
- Psychiatric history of Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia.
- Current Alcoholism or drug abuse.
- Not English or Spanish speaking. Many surveys are not validated in other languages besides English or Spanish. Obtaining interpreters in other languages for palliative care assessments and intervention can be challenging. We expect < 3% of all potentially eligible patients/surrogates to not have English or Spanish speaking ability.
- No healthcare proxy or surrogate also consenting to participate.
- Expected to be discharged to a location >20 miles from Columbia University Medical Center. This discharge radius will make in-person 1-month follow-up feasible.
- Status post heart, lung, or liver transplantation. These patients are not representative of the larger population of older adult survivors of acute respiratory failure.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Palliative Care Consultation
After enrollment the palliative care consultation team will meet with the patient-surrogate pair one or more times to (1) assess symptoms, (2) provide supportive counseling, (3) make symptom treatment recommendations to the primary team of physicians, and (4) will address goals of care.
|
The palliative care consultation team will be led by one of the board-certified palliative care physicians at Columbia University Medical Center.
Over one or more visits, the palliative care consultation team will first review intervention participants' medical records and baseline Edmonton Symptom Assessment System (ESAS) scores.
They will also directly assess participants' physical and psychological symptoms.
They will provide supportive counseling, make treatment recommendations for burdensome symptoms to the primary team of physicians, and will address goals of care.
They will document these activities in structured electronic medical record consultation notes.
다른 이름들:
|
|
위약 비교기: Usual Care
Patient-surrogate pairs randomized to usual care will continue to receive care by their primary physicians without having a palliative care consultation intervention offered.
|
Patient-surrogate pairs randomized to usual care will not have a palliative care consultation intervention offered, and will receive care by their primary physicians.
However, if a palliative care consultation is requested after randomization to usual care by the primary team of physicians and/or the patient/surrogate, it will be provided.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Annual enrollment rate
기간: 1 year
|
The number of patients who enroll compared to the number of patients who enroll and decline enrolling over 1 year
|
1 year
|
|
Adherence to the palliative care consultation intervention
기간: From date of Randomization until the date of hospital discharge or 28 days later.
|
Proportion of patient-surrogate pairs randomized to a palliative care consultation who actually agree to have the palliative care consultation prior to hospital discharge.
|
From date of Randomization until the date of hospital discharge or 28 days later.
|
|
Crossover from usual care to post-ICU palliative care
기간: From date of Randomization until the date of hospital discharge or 28 days later.
|
Proportion of patient-surrogate pairs randomized to usual care who end up receiving a post-ICU palliative care consultation prior to hospital discharge.
|
From date of Randomization until the date of hospital discharge or 28 days later.
|
|
Fidelity of the palliative care intervention
기간: From date of Randomization until the date of hospital discharge or 28 days later.
|
Documentation in electronic medical record consultation notes of (a) burdensome symptoms, (b) supportive counseling, (c) symptom treatment recommendations, and (d) addressing goals-of-care.
|
From date of Randomization until the date of hospital discharge or 28 days later.
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Edmonton Symptom Assessment System (ESAS) scores
기간: Pre-randomization baseline until the date of hospital discharge or 28 days later, and 1-month follow-up after hospital discharge.
|
Changes in patients' ESAS symptoms (best(0) to worse(10)) from randomization to hospital discharge, and from hospital discharge to 1-month follow-up.
ESAS symptoms are: pain, fatigue, drowsiness, nausea, lack of appetite, depression, anxiety, shortness of breath, and wellbeing.
|
Pre-randomization baseline until the date of hospital discharge or 28 days later, and 1-month follow-up after hospital discharge.
|
|
Change in Hospital Anxiety and Depression Scores (HADS) for surrogates
기간: Pre-randomization baseline until the date of hospital discharge or 28 days later, and 1-month follow-up after hospital discharge.
|
Changes in surrogates' HADS scores (best(0) to worst(42)) from randomization to hospital discharge, and from hospital discharge to 1-month follow-up.
|
Pre-randomization baseline until the date of hospital discharge or 28 days later, and 1-month follow-up after hospital discharge.
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of patients with moderate-to-severe fatigue who are recommended for and receive methylphenidate treatment.
기간: Randomization until 1-month follow-up after hospital discharge.
|
Number of patients with ESAS fatigue scores greater than or equal to 4 at baseline who are recommended for and receive methylphenidate treatment.
|
Randomization until 1-month follow-up after hospital discharge.
|
|
New limitation of life-sustaining therapy
기간: Day of hospital discharge until 3-month follow-up after hospital discharge.
|
Number of patients who elect DNR after randomization
|
Day of hospital discharge until 3-month follow-up after hospital discharge.
|
|
Enrollment in Hospice
기간: Day of hospital discharge until 3-month follow-up after hospital discharge.
|
Number of patients who enroll in-patient hospice or home hospice.
|
Day of hospital discharge until 3-month follow-up after hospital discharge.
|
|
Acute-care readmissions
기간: Day of hospital discharge until 3-month follow-up after hospital discharge.
|
Number of patients who are re-admitted to an acute care hospital within 1-month and 3-months.
|
Day of hospital discharge until 3-month follow-up after hospital discharge.
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Matthew R Baldwin, MD, MS, Columbia University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Palliative Care Consultation에 대한 임상 시험
-
University of AlbertaUniversity Hospital Foundation완전한
-
Boston Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD); Center for Community...완전한비만 | 천식 | 혈압 | 아동 발달 | 건강관리 활용 | 아동학대 | 의료 격차 | 기본적인 미충족 사회적 욕구미국
-
University Health Network, Toronto모병림프종 | 림프 증식 장애 | 유방암 1기 | 유방암 2기 | 대장암 2기 | 대장암 3기 | 유방암 3기 | 대장암 1기 | 두경부암 3기 | 유방암, 0기 | 두경부암 1기 | 두경부암 2기캐나다
-
Emory UniversityFoundation for Physical Therapy, Inc.완전한
-
The Hospital for Sick Children모집하지 않고 적극적으로
-
New York UniversityIndiana University; Moi University완전한
-
New York UniversitySt. Luke's-Roosevelt Hospital Center완전한